Home
Shares
News Centre
F&O
Mutual Funds
IPO
Portfolio
Commodity
Loans
Financial Planning
Insurance
About Us
Markets
Companies
Research
Industries
E-Mail Page
Get NAV
Snapshot
Portfolio
Dividends
News
Interviews
Charts
Get Quote
Snapshot
Charts
Financials
Research
News
Wealth Tracker
Tax Corner
NRI Centre
Chat Masala
Feedback
my
Last 5 Scrips
Company
BSE Price(Rs)
% Chg
Yes Bank
24.08
42.49
Tata Stl
136.20
30.33
Ong Corp
256.00
95.64
I T C Lt
438.65
28.62
Ntpc Ltd
319.00
89.15
Clear All
Clear Last
Equity
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
News Watch
Sector Watch
Economy Watch
News-Cipla Limited
Cipla Limited
Sector:Pharmaceuticals
Pharmaceuticals - Bulk Drugs and Formulations
BSE:
500087
NSE:
CIPLA
Bloomberg:
CIPLA@IN
Reuters:
CIPL.BO
Market Lot: 1
Face Value: 2
ISIN Demat: INE059A01026
Quotes
Snapshot
Charts
Financials
Research
Recent News
Peer Group
AGM/AM
MF Holding
Discussion Forum
BSE/NSE Notices
BSE/NSE Deals
Corporate News
20-Dec-2021
Cipla gets final nod for Lanreotide Injection
IRIS
21-Sep-2021
Cipla rises on subscribing 5% stake in Swasth Digital Health Foundation
IRIS
12-Aug-2021
Cipla gets USFDA final nod for Difluprednate Ophthalmic Emulsion
IRIS
23-Jun-2021
Cipla receives final approval for Arformoterol Tartrate Inhalation Solution
IRIS
20-May-2021
Cipla launches RT-PCR test kit ViraGen for COVID-19
IRIS
10-May-2021
Cipla inches up on signing licensing pact with Eli Lilly
IRIS
05-May-2021
Cipla???s associate company incorporates wholly-owned subsidiary
IRIS
29-Apr-2021
Cipla enters into licensing agreement with MSD
IRIS
Home
|
Shares
|
F&O
|
Mutual Funds
|
Loans
|
Insurance
|
News Centre
Wealth Tracker
|
Tax Corner
|
NRI Centre
|
Search in myiris
|
Advertise
� All rights reserved. IRIS Business Services Limited
Disclaimer